Characteristics of amino acid profile and incretin hormones in patients with gallstone disease - a pilot study.
Gallstone disease is associated with insulin resistance, type 2 diabetes mellitus and increased risk of incident ischemic heart disease. It is known that branched-chain amino acids (BCAAs) profile is altered in cardiac diseases and in metabolic diseases, such as diabetes, obesity. The role of BCAAs in gallstone disease is still not known. The aim of this study was to evaluate the concentration of essential amino acids and incretin hormones in patients with cholecystolithiasis. The study included 31 patients with cholecystolithiasis and 25 gallstone-free controls. Free exogenous and endogenous amino acids, bile acids, glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), ghrelin, C-peptide and insulin were measured in the fasting state and one hour after consumption of a 300-kcal mixed meal. The mean fasting and postprandial levels of BCAAs: valine, isoleucine, leucine and lysine were significantly higher in the study group than in the controls (p=0.005 - <0.001). The percentage increase in concentrations of amino acids after a meal were similar in both groups of patients. The mean fasting concentrations of C-peptide and GLP-1 were higher in the study group than in the control group (p=0.004 and p=0.03, respectively), and the median postprandial concentration of C-peptide was higher in the study group as compared to the control group (p=0.03). Diabetes mellitus, coronary heart disease and gallstone disease might have common genetic and environmental antecedents. However, higher plasma levels of BCAAs observed in patients with gallstone disease may be partly responsible for metabolic complications observed in these patients.